TCEB and VISA Unveil Exclusive MICE Privileges Campaign
Discover the Enchanting Allure of Thailand\'s Premier MICE Experiences with Exclusive Benefits through the "Thailand MICE Visa Prepaid Card"
OCI Global Announces Repurchase of OCI Methanol Minorities
AMSTERDAM,Sept. 10,2024-- OCI Global (Euronext: OCI),("OCI",the "Company"),a leading global producer and distributor of hydrogen products today announced that it has reached agreem
The 2024 International (Bozhou) TCM Expo Kicked Off
BOZHOU,China,Sept. 10,2024-- On the morning of September 9,the 2024 International (Bozhou) TCM Expo and the 40th National (Bozhou) TCM Trade Fair officially kicked off in Bozhou,Anhui Province.
IBM Launches New Services to Help Oracle Clients Extend Generative AI
Expanded network of consulting experts will help clients maximize generative AI investments,optimize compute and implementation costs
Good Media: "Sky City, Endless Possibilities" - Shenzhen's Autumn Tourism Plan Released
A spectacular drone show for 7 consecutive days during the National Day holiday,inviting global tourists
GAIN Summit 2024 opens its doors
Third edition of the Global Artificial Intelligence Summit begins in Riyadh RIYADH,Saudi Arabia,Sept. 11,2024-- AI leaders from around the world have gathered for day one of the Global AI Summit (GAIN
Yiwugo: Pearls and Silver Jewelry Take the Global Accessories Market by Storm
YIWU,China,Sept. 6,2024-- Yiwugo.com,the official website of the Yiwu Commodity Market,is the largest commodity wholesale market in the world. As a long-standing popular export category from Yiwu to
BEIJING,Sept. 8,2024-- More than 600 dignitaries and representatives from sectors of shipping,trade,finance and technology in the world attended the 6th Silk Road Maritimes International Cooperation F
- Supporting Customers\' Business Expansion with Higher-quality Services as Trusted Partner - TOKYO,Sept. 9,2024-- Nippon Express Automotive Logistics (China) Co.,Ltd. (hereafter "NX Automotive L
Senhwa Biosciences Presents Clinical Data Abstract on Pidnarulex at 2024 ESMO Congress
The study involved end-stage oncology patients with no other suitable treatment options. In this Phase Ib study,Pidnarulex (CX-5461) demonstrated acceptable clinical tolerability and showed prelimina